AML1-ETO is determined by t (8; 21) (q22; Q22) chromosomal translocation of tumor proteins, which are seen in 1%–5% of patients with acute myeloid leukemia, most often in younger patients. This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.